The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction

The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction

Purpose We investigated the effectiveness of intravesical botulinum toxin-A (BTX-A) injection therapy in patients with lower urinary tract dysfunction (LUTD) and upper urinary tract (UUT) deterioration and evaluated whether BTX-A injection therapy could substitute for augmentation uretero-enterocyst...

Full description

Bibliographic Details
Main Authors:	Xuesheng Wang, Zhonghan Zhou, Limin Liao
Format:	Article
Language:	English
Published:	Korean Continence Society 2023-03-01
Series:	International Neurourology Journal
Subjects:	botulinum toxin-a injection augmentation uretero-enterocystoplasty lower urinary tract dysfunction bladder function upper urinary tract function
Online Access:	http://einj.org/upload/pdf/inj-2244220-110.pdf

Similar Items

Augmentation Uretero-enterocystoplasty Is an Effective Procedure in Protecting the Upper Urinary Tract Without Accelerating Deterioration of Renal Function
by: Xuesheng Wang, et al.
Published: (2023-05-01)

The concerns of mechanical upper urinary tract obstruction in neurogenic lower urinary tract dysfunction: Beyond augmentation cystoplasty
by: Zhonghan Zhou, et al.
Published: (2023-03-01)

Comparison of Enterocystoplasty and Ureterocystoplasty before Kidney Transplantation
by: R. Mahdavi Zafarghandi, et al.
Published: (2010-10-01)

Does botulinum therapy affect the urine microbiome of patients with neurogenic bladder? Metagenomic sequencing results
by: E. S. Philippova, et al.
Published: (2020-10-01)

Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A
by: Hann-Chorng Kuo
Published: (2024-05-01)

Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux
by: Han-Chao Zhang, et al.
Published: (2016-06-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients
by: Chih-Chieh Lin, et al.
Published: (2022-01-01)

Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients
by: Shu-Yu Wu, et al.
Published: (2017-06-01)

Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions
by: Yuan-Hong Jiang, et al.
Published: (2024-03-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Upper urinary dilatation and treatment of 26 patients with diabetes insipidus: A single-center retrospective study
by: Xuesheng Wang, et al.
Published: (2022-07-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence
by: Margarida Manso, et al.
Published: (2024-07-01)

The cause analysis of benign uretero-ileal anastomotic stricture after radical cystectomy and urinary diversion
by: Zhenghong Liu, et al.
Published: (2022-12-01)

Long-term Outcomes of Augmentation Enterocystoplasty with an Ileal Segment in Patients with Spinal Cord Injury
by: Jing-Liang Chen, et al.
Published: (2009-06-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
by: Bing-Juin Chiang, et al.
Published: (2019-09-01)

Bladder onabotulinum toxin A injections and patients: Office-based vs. operating room setting
by: Daniele Bianchi, et al.
Published: (2024-06-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Reliability assessment of the upper urinary tract dilation grading system based on magnetic resonance urography in patients with neurogenic bladder
by: Zhonghan Zhou, et al.
Published: (2022-07-01)

Risk factors for urinary tract infection in children with urinary urgency
by: Rhaiana Gondim, et al.

Long-term Outcomes of Periurethral Sphincter Botulinum Toxin in Female Chronic Urinary Retention
by: Sarah L. Wright, et al.
Published: (2024-09-01)

Augmentation uretero-enterocystoplasty for refractory urinary tract dysfunction: a long-term retrospective study
by: Xiaoqian Ying, et al.
Published: (2021-11-01)

Managing the urinary tract in spinal cord injury
by: Simon C.W Harrison
Published: (2010-01-01)

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
by: Yu-Chao Hsu, et al.
Published: (2016-04-01)

A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
by: Yi-Huei Chang, et al.
Published: (2020-06-01)

Villous Adenoma Arising in the Urethra of a Female with Bladder Augmentation History: A Case Report and Review of the Literature
by: Hale DEMIR, et al.
Published: (2021-05-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder
by: Seong Jin Jeong, et al.
Published: (2020-09-01)

Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
by: Po-Cheng Chen, et al.
Published: (2023-04-01)

Abnormal urodynamic changes in post-upper urinary tract dysfunction in ureteral obstruction rat models
by: Xin Liu, et al.
Published: (2024-01-01)

Revisit the rare clinical cases of upper urinary tract metastases from gastrointestinal tumors
by: Keyang Jia, et al.
Published: (2023-02-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

Sudden fatal bleeding from a uretero-arterial fistula combined with pre-existing uretero-colic and uretero-vaginal fistulas 7 years after a cervical cancer surgery: a case report
by: Hiroki Yamazaki, et al.
Published: (2019-05-01)

Long-Term Adherence to Onabotulinum Toxin-A Intradetrusor Injections for Neurogenic Dysfunction in Children—A Retrospective Single-Center Evaluation
by: Chiara Pellegrino, et al.
Published: (2024-07-01)